Steven Magill, MD
Basic profileSteven Magill is an Endocrinology/Metabolic physician affiliated with Medical College of Wisconsin. OpenAlex indexes 38 publications with 1,267 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Xeris Pharmaceuticals, Inc.Program year20221 payment$12
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
82.9%Other drugs affecting bone structure and mineralization72.4%Romosozumab-aqqg100%Part B, office-administered≥16 patientsRANK Ligand Inhibitor8.9%Denosumab100%Part B, office-administered≥12 patients+ 1 more class in this area
Metabolism & gastrointestinal
10.1%Insulin Analog4.1%Lantus Solostar34%Humalog Kwikpen U-10014%Novolog Flexpen12%Lantus7%Tresiba Flextouch U-1006%Tresiba Flextouch U-2004%Humalog4%Toujeo Solostar4%Basaglar Kwikpen U-1004%Novolog3%Insulin Lispro Kwikpen U-1003%Toujeo Max Solostar3%Insulin Lispro2%Part D<11 patientsBiguanide (metformin)2.4%Metformin Hcl Er85%Metformin Hcl15%Part D≥87 patients+ 6 more classes in this area
Hormonal (systemic)
5.1%l-Thyroxine3.7%Levothyroxine Sodium80%Synthroid15%Levoxyl5%Part D<11 patientsThyroid Hormone Synthesis Inhibitor0.6%Methimazole100%Part D≥29 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- UNILATERALLY SELECTIVE ADRENAL VEIN SAMPLING FOR IDENTIFICATION OF SURGICALLY CURABLE PRIMARY ALDOSTERONISM
Journal of Hypertension
2023 - THU593 Unilaterally Selective Adrenal Vein Sampling For Identification Of Surgically Curable Primary Aldosteronism
Journal of the Endocrine Society
2023 - Wide Variability in Catecholamine Levels From Adrenal Venous Sampling in Primary Aldosteronism
Journal of Surgical Research
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Brett Kissela, MD
Medical College of Wisconsin
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
David Gutterman, MD
Medical College of Wisconsin
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”